Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alexander J. Ohnmacht"'
Autor:
Alexander J. Ohnmacht, Arndt Stahler, Sebastian Stintzing, Dominik P. Modest, Julian W. Holch, C. Benedikt Westphalen, Linus Hölzel, Marisa K. Schübel, Ana Galhoz, Ali Farnoud, Minhaz Ud-Dean, Ursula Vehling-Kaiser, Thomas Decker, Markus Moehler, Matthias Heinig, Volker Heinemann, Michael P. Menden
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-15 (2023)
Abstract Precision medicine has revolutionised cancer treatments; however, actionable biomarkers remain scarce. To address this, we develop the Oncology Biomarker Discovery (OncoBird) framework for analysing the molecular and biomarker landscape of r
Externí odkaz:
https://doaj.org/article/6154ff20ebe74724a6a6c7ebb50722a3
Autor:
Phong Nguyen, Ana Galhoz, Alexander J Ohnmacht, Fabian J. Theis, Maren Büttner, Michael P. Menden
Publikováno v:
Der Diabetologe. 17:788-798
Diabetes mellitus entwickelt sich zu einem globalen Gesundheitsproblem, das eine Transformation der Forschung und der medizinischen Praxis fur ein besseres Patientenmanagement erfordert. Diesbezuglich bieten die Fulle an Daten und die Fortschritte in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33107bed26c50ce2f53b00af5ea716ac
https://doi.org/10.1007/s11428-021-00817-w
https://doi.org/10.1007/s11428-021-00817-w
Publikováno v:
Expert Opinion on Drug Discovery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::075bc16ca614ff7b3a2e5b0e6ab2026a
Autor:
Michael P. Menden, Benjamin Schubert, Dieter Saur, Alexander J Ohnmacht, Fabio Boniolo, Emilio Dorigatti
Publikováno v:
Expert Opin. Drug Discov. 16, 991-1007 (2021)
Expert Opinion on Drug Discovery
Expert Opinion on Drug Discovery
Introduction: Precision medicine is the concept of treating diseases based on environmental factors, lifestyles, and molecular profiles of patients. This approach has been found to increase success rates of clinical trials and accelerate drug approva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::390237e3f21f57726ecc4551a1749a4a
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=62209
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=62209
Publikováno v:
Int. J. Mol. Sci. 22:10135 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 18
International Journal of Molecular Sciences, Vol 22, Iss 10135, p 10135 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 18
International Journal of Molecular Sciences, Vol 22, Iss 10135, p 10135 (2021)
Disparities between risk, treatment outcomes and survival rates in cancer patients across the world may be attributed to socioeconomic factors. In addition, the role of ancestry is frequently discussed. In preclinical studies, high-throughput drug sc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::164ebe057a778e2edeba1f387fecf526
https://doi.org/10.3390/ijms221810135
https://doi.org/10.3390/ijms221810135